Publications by authors named "Zhao-Yan Cheng"

Claim this Profile
D
Dopamine D2 receptor agonist Bromocriptine ameliorates Aβ-induced memory deficits and neuroinflammation in mice.
Xin Liu, Zhao-Yan Cheng, Yan-Feng Li, Chao Liu, Chen Wang

Eur J Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model.
Zhao-Yan Cheng, Yu-Hui Hu, Qing-Peng Xia, Chen Wang, Ling He

Brain Res Bull· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.
Chao Liu, Zhao-Yan Cheng, Qing-Peng Xia, Yu-Hui Hu, Chen Wang

Psychopharmacology (Berl)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine D1 receptor agonist A-68930 ameliorates Aβ-induced cognitive impairment and neuroinflammation in mice.
Zhao-Yan Cheng, Qing-Peng Xia, Yu-Hui Hu, Chen Wang, Ling He

Int Immunopharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The modulatory role of dopamine receptors in brain neuroinflammation.
Qing-Peng Xia, Zhao-Yan Cheng, Ling He

Int Immunopharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ-induced cognitive impairment.
Xuan Zang, Zhao-Yan Cheng, Yi Sun, Nan Hua, Li-Hua Zhu

Prog Neuropsychopharmacol Biol Psychiatry· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis